Christie + Co
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation Links
EQT to buy BSN Medical for €1.8 billion

Private equity fund EQT VI has agreed to buy medical device manufacturer BSN Medical from Montagu Private Equity for €1.8 billion (£1.4 billion).

BSN has annual sales of €700 million and around 4,000 employees. It is a major supplier of wound care, compression therapy and orthopaedic products to hospitals and pharmacies around the world.

The company was founded in 2001 as a joint venture between Beiersdorf AG and Smith & Nephew, and was acquired by Montagu Private Equity in 2005.

“We view BSN as a highly attractive growth case with strong resilience across the business cycle,” said Marcus Brennecke, partner at EQT Partners in Germany, and investment advisor to EQT VI.

“While continuing to strengthen the position in key markets and in key product segments, there is tremendous potential in entering new geographic markets, especially in Asia and Latin America. BSN’s global foot-print and large sales force provide an excellent platform for add-on acquisitions.”

BSN’s chief executive, Claus-H Wiegel, said: “We will look forward to working with EQT to deliver the next phase of BSN’s growth story.”

The transaction is subject to regulatory clearances. Morgan Stanley and Deutsche Bank acted as financial advisors to EQT VI. Goldman Sachs and HSBC acted as financial advisors to Montagu and BSN.

Posted on: 11/06/2012

Latest news stories

31/05/2016
Cancer treatment proton therapy systems developer Advanced Oncotherapy (AVO) secured key funding in the financial year ended 31 December 2015.
27/05/2016
Target Healthcare REIT has acquired a new care home in Halifax, West Yorkshire from Ideal Care (North).
27/05/2016
Care Quality Commission director of strategy and intelligence Paul Bate is to leave the regulator for digital health company babylon.
27/05/2016
Commissioners in North East London have agreed to allow Care UK to continue to run a treatment centre in the area after the provider complained to NHS Improvement (NHSI, formerly Monitor).
26/05/2016
75% of NHS trust chairs and chief executives feel that a ‘Brexit’ would have a negative impact on the NHS, according to a survey.




Voyage’s new CEO Andrew Cannon tells Ploy Radford the operator is in a good place for raising its profile in the LD space
Read more...


Christie+Co

Northern Ireland is often overlooked as an area for investment in care, but the integrated model of care so many wish for in England is in place already in the region, finds Luke Cloherty
Read more...


The creation of NHS Improvement could see private sector opportunities dwindle, argues Thomas Cawston
Jungle Production co-founder Allan Johnston tells HealthInvestor about how his production company is helping the healthcare sector
Bridgepoint Development Capital has built upon its dental and European roots with Acteon acquisition
Clare Connell and Charlotte Bushnell of Connell Consulting analyse the efficiency of the new agency cap
London Care Partnership has successfully tapped into the South West London specialist care market. Ploy Radford hears about the key to its success

Click here to search all feature articles